- Previous Close
3.2900 - Open
3.2900 - Bid --
- Ask --
- Day's Range
3.2900 - 3.4900 - 52 Week Range
2.4300 - 21.6000 - Volume
47,261 - Avg. Volume
371,385 - Market Cap (intraday)
3.623M - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
-- - EPS (TTM)
-20.1000 - Earnings Date Aug 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.
www.avalon-globocare.comRecent News: ALBT
View More
Performance Overview: ALBT
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALBT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALBT
View MoreValuation Measures
Market Cap
3.51M
Enterprise Value
31.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.87
Price/Book (mrq)
--
Enterprise Value/Revenue
24.39
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.19%
Return on Equity (ttm)
-128.85%
Revenue (ttm)
-7.53M
Net Income Avi to Common (ttm)
-14.54M
Diluted EPS (ttm)
-20.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
200.57k
Total Debt/Equity (mrq)
187.39%
Levered Free Cash Flow (ttm)
-4.87M
Company Insights: ALBT
ALBT does not have Company Insights